BioMed Research Updates: ARRY, ACCP.OB, MCLN.OB Print E-mail
Wednesday, 16 December 2009 19:31

Below are four stock research reports published within the past week and available to view or download at the BioMedReports.com research downloads section.

 

1.) Array BioPharma (NASDAQ: ARRY) Rodman & Renshaw 12/14/09

Rated Market Outperform / Speculative Risk

12-Month Price Target of $10, Last Price $2.66

2.) Access Pharma (OTC: ACCP.OB) NextWave Research 12/16/09

Rated Spec Buy, $7 Price Target, Last Price $3.20

3.) MedClean Technologies (OTC: MCLN.OB) Goldman Small Cap Research 12/9/09

Rated Spec Buy with Near-Term Price Target $0.14, 2010 Price Target $0.40, Last Price $0.03

Disclosure: Long ACCP.OB




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter